Samsung Medical Center
Sigmoid adenocarcinoma treatment cost in the Republic of Korea is influenced by the disease stage and the surgical approach, with a consultation with an oncologist typically ranging from $27 to $100. Primary treatments such as a colectomy run from $16,500 to $29,800. Patients often save approximately 30-50% compared to the US. Most specialized care is concentrated in Seoul, Incheon, and Seongnam.
Typical Sigmoid Adenocarcinoma Treatment Costs in Republic of Korea
Bookimed Expert Insight: High-risk patients benefit from the digital safety systems at Seoul National University Bundang Hospital. For advanced cases, Samsung Medical Center provides multidisciplinary care with Da Vinci robotic technology. Patients seeking scarring reduction should consider Ewha Womans University Medical Center for minimally invasive expertise. Korea University Anam Hospital remains a leader for complex robotic cancer surgeries to minimize infection risks.
| Republic of Korea | Turkey | Austria | |
| Colectomy (large bowel resection) | from $16,500 | from $6,912 | from $22,000 |
| Chemotherapy for breast cancer | from $19,200 | from $1,200 | from $15,000 |
| Radiation therapy for colorectal cancer | - | from $7,000 | from $12,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Sigmoid adenocarcinoma treatment and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Sigmoid adenocarcinoma treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Sigmoid adenocarcinoma treatment journey.
The doctor is a leading breast cancer specialist in South Korea and is recognized among the world’s top 100 gastric and breast cancer surgeons. The doctor pioneered breast conserving surgery in South Korea in 1986 and invented a unique stomach cancer surgery that minimizes the risk of gastroesophageal reflux disease. The doctor currently heads the Cancer Center for Women at Ewha Womans University Medical Center and has previously served as President of Konkuk University Hospital and Director of Korea Cancer Center Hospital. The doctor is also an active researcher in breast cancer diagnosis and management.
The doctor is the Head of the Oncology Department, specializing in chemotherapy for lung cancer, head and neck cancer, and esophageal cancer. The focus is on utilizing new clinical drugs to improve treatment outcomes. With extensive experience in oncological therapies, the doctor is at the forefront of cancer treatment advancements.
The doctor is an expert in oncoplastic surgery and breast cancer, with extensive experience from prestigious institutions. The doctor holds an M.D. degree from Seoul National University College of Medicine and an M.S. degree in Surgery from the same institution. Additionally, the doctor earned a B.S. in biological sciences from the Korea Advanced Institute of Science and Technology (KAIST) and a Ph.D. in Surgery from Seoul National University Graduate School.
The doctor is a prominent figure in the field of surgery, holding leadership roles such as Director of the Training and Education Committee at the Korean Surgical Society and Director of the Information Technology Committee at the Korean Society of Coloproctology. The doctor also serves as Director of the Surgical Affairs Board at the Korean Society of Gastroenterology and Vice President of the Korean Association of Robotic Surgeons.
With a robust educational background from Korea University, the doctor has demonstrated surgical expertise internationally, including at the Faculty of Medicine, Chinese University of Hong Kong, and Tan Tock Seng Hospital in Singapore.
South Korean protocols for sigmoid adenocarcinoma prioritize minimally invasive surgery and multidisciplinary care. Laparoscopic resection rates reach 78% in top facilities. Standard protocols include robotic colectomy using Da Vinci systems. Oncologists typically prescribe FOLFOX regimens for high-risk stage 2 or stage 3 cases.
Bookimed Expert Insight: Clinics like Asan Medical Center and Severance Hospital handle massive patient volumes, often exceeding 1 million outpatients annually. This high frequency allows surgeons to specialize intensely. For example, Korea University Anam Hospital focuses on bloodless robotic techniques. This specialization reduces infection risks and speeds up post-operative recovery times.
Patient Consensus: Patients note the efficiency of the Korean medical system, where staging and surgery often happen quickly. They emphasize confirming whether a tumor is classified as colon or rectosigmoid, as this changes radiation needs.
South Korea houses several globally recognized institutions for sigmoid colon cancer surgery, including Samsung Medical Center, Asan Medical Center, and Severance Hospital. These centers maintain JCI accreditation and Newsweek rankings. They specialize in minimally invasive laparoscopic and robotic colectomy procedures for precise tumor removal.
Bookimed Expert Insight: While most major Seoul hospitals share high Newsweek rankings, the technical approach differs by facility. Korea University Anam Hospital stands out for patients prioritizing recovery speed due to their specialized bloodless surgery protocols. Meanwhile, Seoul National University Hospital is the preferred choice for complex cases since it serves as the official treatment center for South Korea’s president.
Patient Consensus: Patients note that major Seoul centers provide coordinated multidisciplinary care. Many emphasize choosing a surgeon based on their specific experience with robotic sigmoid colectomy rather than hospital ranking alone.
Korean hospitals extensively offer robotic-assisted surgery for sigmoid adenocarcinoma using the Da Vinci surgical system. Major JCI-accredited centers in Seoul utilize these platforms to perform precise colectomies. This approach currently accounts for approximately 12.7% of colorectal cancer cases nationwide. These facilities specialize in minimally invasive resections.
Bookimed Expert Insight: While many centers offer robotic platforms, the real differentiator is surgical volume. Seoul National University Hospital maintains the highest cancer treatment statistics in the country. Our data shows hospitals with over 30,000 annual operations often provide better access to specialized robotic teams for complex sigmoid cases.
Patient Consensus: Patients emphasize finding a surgeon with significant case experience rather than just selecting a clinic with robot availability. They note that while recovery is often faster, confirming your specific tumor stage and pathology first is essential.
South Korean oncology centers report some of the highest long-term survival rates globally for colorectal cancers. Patients treated for sigmoid adenocarcinoma benefit from advanced robotic surgery and multidisciplinary care. Most leading Seoul hospitals maintain JCI accreditation and survival outcomes that frequently exceed OECD averages.
Bookimed Expert Insight: Korea's survival advantage stems from massive surgical volumes. Centers like Asan Medical Center perform over 65,000 operations annually. This high frequency allows surgeons to master bloodless techniques. These methods reduce infection risks and accelerate patient recovery times compared to lower-volume international centers.
Patient Consensus: Patients note that care is exceptionally fast and efficient. Most report returning to normal life quickly, though they emphasize the importance of sticking to strict dietary adjustments and follow-up scan schedules during the first few years.
Medical tourists should plan a 14 to 28 day stay in South Korea for sigmoid adenocarcinoma surgery. This timeframe allows for preoperative testing and inpatient recovery. A mandatory 14-day post-operative period ensures safety before long-haul flights. Total stay length depends on pathology results and chemotherapy needs.
Bookimed Expert Insight: Korea's digital healthcare infrastructure significantly speeds up the diagnostic phase. Hospitals like Seoul National University Bundang Hospital use fully digital patient systems. Samsung Medical Center treats over 2,000,000 patients annually with presidential-level standards. This high volume often results in more efficient pathology processing than other medical hubs. Most major Seoul clinics also offer robotic surgery through Da Vinci systems. These minimally invasive options can reduce hospital nights compared to traditional open surgery.
Patient Consensus: Patients often warn that pathology results can take longer than expected. It is important to confirm if the treatment plan includes only surgery or additional chemotherapy.